659
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Prognostic factors, effectiveness and safety of endoscopic balloon dilatation for de novo and anastomotic strictures in Crohn’s disease—A multicenter “real life” study

, , , ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & | (Reviewing Editor) show all
Article: 1233687 | Received 07 Jul 2016, Accepted 05 Sep 2016, Published online: 08 Oct 2016

References

  • Brenmoehl, J., Falk, W., Göke, M., Schölmerich, J., & Rogler, G. (2008). Inflammation modulates fibronectin isoform expression in colonic lamina propria fibroblasts (CLPF). International Journal of Colorectal Disease, 23, 947–955. doi:10.1007/s00384-008-0523-z
  • Couckuyt, H., Gevers, A. M., Coremans, G., Hiele, M., & Rutgeerts, P. (1995). Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn’s strictures: A prospective longterm analysis. Gut, 36, 577–580.10.1136/gut.36.4.577
  • Endo, K., Takahashi, S., Shiga, H., Kakuta, Y., Kinouchi, Y., & Shimosegawa, T. (2013). Short and long-term outcomes of endoscopic balloon dilatation for Crohn’s disease strictures. World Journal of Gastroenterology, 19, 86–91. doi:10.3748/wjg.v19.i1.86
  • Ferlitsch, A., Reinisch, W., Püspök, A., Dejaco, C., Schillinger, M., Schöfl, R., ... Vogelsang, H. (2006). Safety and efficacy of endoscopic balloon dilation for treatment of Crohn’s disease strictures. Endoscopy, 38, 483–487. doi:10.1055/s-2006-924999
  • Greenstein, A. J., Sachar, D. B., Pasternack, B. S., & Janowitz, H. D. (1975). Reoperation and recurrence in Crohn’s colitis and ileocolitis. New England Journal of Medicine, 293, 685–690. doi:10.1056/NEJM197510022931403
  • Gustavsson, A., Magnuson, A., Blomberg, B., Andersson, M., Halfvarson, J., & Tysk, C. (2012). Endoscopic dilation is an efficacious and safe treatment of intestinal strictures in Crohn’s disease. Alimentary Pharmacology & Therapeutics, 36, 151–158. doi:10.1111/j.1365-2036.2012.05146.x
  • Hassan, C., Zullo, A., De Francesco, V., Ierardi, E., Giustini, M., Pitidis, A., ... Morini, S. (2007). Systematic review: Endoscopic dilatation in Crohn’s disease. Alimentary Pharmacology & Therapeutics, 26, 1457–1464. doi:10.1111/j.1365-2036.2007.03532.x
  • Hirai, F., Beppu, T., Takatsu, N., Yano, Y., Ninomiya, K., Ono, Y., ... Matsui, T. (2014). Long-term outcome of endoscopic balloon dilation for small bowel strictures in patients with Crohn’s disease. Digestive Endoscopy, 26, 545–551. doi:10.1111/den.12236
  • Honzawa, Y., Nakase, H., Matsuura, M., Higuchi, H., Toyonaga, T., Matsumura, K., ... Chiba, T. (2013). Prior use of immunomodulatory drugs improves the clinical outcome of endoscopic balloon dilation for intestinal stricture in patients with Crohn’s disease. Digestive Endoscopy, 25, 535–543. doi:10.1111/den.12029
  • Karstensen, J. G., Hendel, J., & Vilmann, P. (2012). Endoscopic balloon dilatation for Crohn’s strictures of the gastrointestinal tract is feasible. Danish Medical Journal, 59, A4471.
  • Louis, E., Collard, A., Oger, A. F., Degroote, E., Aboul Nasr El Yafi, F. A., & Belaiche, J. (2001). Behaviour of Crohn’s disease according to the Vienna classification: Changing pattern over the course of the disease. Gut, 49, 777–782.10.1136/gut.49.6.777
  • Mueller, T., Rieder, B., Bechtner, G., & Pfeiffer, A. (2010). The response of Crohn’s strictures to endoscopic balloon dilation. Alimentary Pharmacology & Therapeutics, 31, 634–639. doi:10.1111/j.1365-2036.2009.04225.x
  • Nakazato, H., Oku, H., Yamane, S., Tsuruta, Y., & Suzuki, R. (2002). A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-α at the translational level. European Journal of Pharmacology, 446, 177–185.10.1016/S0014-2999(02)01758-2
  • Nanda, K., Courtney, W., Keegan, D., Byrne, K., Nolan, B., O’Donoghue, D., ... Doherty, G. (2013). Prolonged avoidance of repeat surgery with endoscopic balloon dilatation of anastomotic strictures in Crohn’s disease. Journal of Crohn’s & Colitis, 7, 474–480. doi:10.1016/j.crohns.2012.07.019
  • Ono, Y., Hirai, F., Matsui, T., Beppu, T., Yano, Y., Takatsu, N., ... Futami, K. (2012). Value of concomitant endoscopic balloon dilation for intestinal stricture during long-term infliximab therapy in patients with crohn's disease. Digestive Endoscopy, 24, 432–438. doi:10.1111/j.1443-1661.2012.01315.x
  • Raedler, A., Peters, I., & Schreiber, S. (1997). Treatment with azathioprine and budesonide prevents recurrence of ileocolonic stenoses. Gastroenterology, 112, A1067.
  • Rutgeerts, P., Geboes, K., Vantrappen, G., Beyls, J., Kerremans, R., & Hiele, M. (1990). Predictability of the postoperative course of Crohn’s disease. Gastroenterology, 99, 956–963.10.1016/0016-5085(90)90613-6
  • Samimi, R., Flasar, M. H., Kavic, S., Tracy, K., & Cross, R. K. (2010). Outcome of medical treatment of stricturing and penetrating Crohnʼs disease. Inflammatory Bowel Diseases, 16, 1187–1194. doi:10.1002/ibd.21160
  • Satsangi, J., Silverberg, M. S., Vermeire, S., & Colombel, J.-F. (2006). The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications. Gut, 55, 749–753. doi:10.1136/gut.2005.082909
  • Scimeca, D., Mocciaro, F., Cottone, M., Montalbano, L. M., D’Amico, G., Olivo, M., ... Orlando, A. (2011). Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn’s disease strictures. Digestive and Liver Disease, 43, 121–125. doi:10.1016/j.dld.2010.05.001
  • Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D. R., Bernstein, C. N., Brant, S. R., ... Warren, B. F. (2005). Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a working party of the 2005 montreal world congress of gastroenterology. Canadian Journal of Gastroenterology, 19, 5A–36A.10.1155/2005/269076
  • Sostegni, R., Daperno, M., Scaglione, N., Lavagna, A., Rocca, R., & Pera, A. (2003). Crohn’s disease: Monitoring disease activity. Alimentary Pharmacology & Therapeutics, 17, 11–17.10.1046/j.1365-2036.17.s2.17.x
  • Theiss, A. L., Simmons, J. G., Jobin, C., & Lund, P. K. (2005). Tumor necrosis factor (TNF) increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2. Journal of Biological Chemistry, 280, 36099–36109. doi:10.1074/jbc.M505291200
  • Thienpont, C., D’Hoore, A., Vermeire, S., Demedts, I., Bisschops, R., Coremans, G., ... Van Assche, G. (2010). Long-term outcome of endoscopic dilatation in patients with Crohn’s disease is not affected by disease activity or medical therapy. Gut, 59, 320–324. doi:10.1136/gut.2009.180182
  • Thomas-Gibson, S., Brooker, J. C., Hayward, C. M. M., Shah, S. G., Williams, C. B., & Saunders, B. P. (2003). Colonoscopic balloon dilation of Crohn’s strictures: A review of long-term outcomes. European Journal of Gastroenterology & Hepatology, 15, 485–488. doi:10.1097/01.meg.0000059110.41030.bc
  • Vassallo, R., Matteson, E., & Thomas, C. F. J. (2002). Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-α inhibition. Chest, 122, 1093–1096.10.1378/chest.122.3.1093
  • Wibmer, A. G., Kroesen, A. J., Gröne, J., Buhr, H.-J., & Ritz, J.-P. (2010). Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn’s disease–review of the literature. International Journal of Colorectal Disease, 25, 1149–1157. doi:10.1007/s00384-010-1010-x